Titlebook: Breast Cancer: From Bench to Personalized Medicine; Saima Shakil Malik,Nosheen Masood Book 2022 The Editor(s) (if applicable) and The Auth

Gorilla

ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying gene978-981-19-0199-7978-981-19-0197-3

Resign

coalition

Carolin Maja Gebhardt,Dominik Niopeko manifestation of disease for almost 40?years of the age. Some of the significant contributing factors of the disease include harmful alcohol use, age, obesity, family history, exposure to harmful radiations, and reproductive factors. Besides, some factors are responsible for aggravating the incide

BOGUS

慎重

The TRPCs–STIM1–Orai Interactionn this chapter. The genetic basis for hormone-dependent tumors, relationships between breast and other hormonal cancer, and biomarker correlation that has recently been recognized are also covered in this chapter.

Semblance

magnate

圖畫文字

https://doi.org/10.1007/978-3-642-54215-2motherapy is affected due to the cancer characteristics and by molecular classification. Molecular classification of breast cancer based on estrogen receptor negative group such as HER2 enriched, normal breast, and basal shaped is more sensitive to chemotherapy as compared to estrogen receptor posit

Synovial-Fluid

話

Victor J. Wilson,Geoffrey Melvill Jonesence of the DNA, making them not only an attractive candidate as a prognostic and diagnostic biomarker but also a potential therapeutic target. Aberrant epigenetic modifications, namely, histone modifications, DNA methylation, and non-coding RNAs (ncRNAs) have a crucial role in initiating breast car